Sonoma Pharmaceuticals (SNOA) Shares Outstanding (Weighted Average) (2016 - 2022)
Sonoma Pharmaceuticals (SNOA) has 3 years of Shares Outstanding (Weighted Average) data on record, last reported at $35879.0 in Q4 2012.
- For Q4 2012, Shares Outstanding (Weighted Average) rose 32.79% year-over-year to $35879.0; the TTM value through Dec 2012 reached $35879.0, up 32.79%, while the annual FY2012 figure was $27.4 million, 3.84% up from the prior year.
- Shares Outstanding (Weighted Average) reached $35879.0 in Q4 2012 per SNOA's latest filing, up from $32111.0 in the prior quarter.
- Across five years, Shares Outstanding (Weighted Average) topped out at $27.4 million in Q1 2012 and bottomed at $26711.0 in Q2 2011.
- Average Shares Outstanding (Weighted Average) over 3 years is $12.1 million, with a median of $35879.0 recorded in 2012.
- Peak YoY movement for Shares Outstanding (Weighted Average): crashed 99.9% in 2011, then skyrocketed 32.79% in 2012.
- A 3-year view of Shares Outstanding (Weighted Average) shows it stood at $26.4 million in 2010, then crashed by 99.9% to $27020.0 in 2011, then surged by 32.79% to $35879.0 in 2012.
- Per Business Quant database, its latest 3 readings for Shares Outstanding (Weighted Average) were $35879.0 in Q4 2012, $32111.0 in Q3 2012, and $31601.0 in Q2 2012.